Causes of Death and End-of-Life Care in Patients With Intracranial High-Grade Gliomas A Retrospective Observational Study

被引:8
|
作者
Barbaro, Marissa [1 ,4 ,5 ]
Blinderman, Craig D. [2 ,3 ]
Iwamoto, Fabio M. [2 ]
Kreisl, Teri N. [1 ,6 ,7 ]
Welch, Mary R. [1 ,2 ]
Odia, Yazmin [1 ,8 ]
Donovan, Laura E. [1 ,2 ,9 ,10 ]
Joanta-Gomez, Adela E. [2 ]
Evans, Katharine A. [1 ,11 ]
Lassman, Andrew B. [1 ,2 ]
机构
[1] Herbert Irving Comprehens Canc Ctr, Div Neurooncol, Irving, TX USA
[2] Herbert Irving Comprehens Canc Ctr, Dept Neurol, Irving, TX USA
[3] Columbia Univ, Vagelos Coll Phys & Surg, Div Hematol Oncol, New York, NY USA
[4] Columbia Univ, Dept Med, Vagelos Coll Phys & Surg, Palliat Care Serv Sect,New York Presbyterian Hosp, New York, NY USA
[5] NYU, Langone Hematol Oncol Associates Mineola, Perlmutter Canc Ctr, New York, NY USA
[6] NYU Langone Hlth, NYU Long Isl Sch Med, New York, NY USA
[7] Novartis AG, Basel, Switzerland
[8] Miami Canc Inst, Miami, FL USA
[9] Baptist Hlth South Florida, Miami, FL USA
[10] James J Peters Med Ctr, Dept Vet Affairs, Bronx, NY USA
[11] Montefiore Hlth Syst, Bronx, NY USA
关键词
BRAIN-TUMOR PATIENTS; PALLIATIVE CARE; AMERICAN SOCIETY; CANCER-PATIENTS; PATTERNS; PHASE; GLIOBLASTOMA; INTEGRATION; PREDICTORS; ONCOLOGY;
D O I
10.1212/WNL.0000000000013057
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Objectives To understand patterns of care and circumstances surrounding end of life in patients with intracranial gliomas. Methods We retrospectively analyzed end-of-life circumstances in patients with intracranial high-grade gliomas at Columbia University Irving Medical Center who died from January 2014 to February 2019, including cause of death, location of death, and implementation of comfort measures and resuscitative efforts. Results There were 152 patients (95 men, 57 women; median age at death 61.5 years, range 24-87 years) who died from January 2014 to February 2019 with adequate data surrounding end-of-life circumstances. Clinical tumor progression (n = 117, 77.0%) was the most common cause of death, with all patients transitioned to comfort measures. Other causes included, but were not limited to, infection (19, 12.5%); intratumoral hemorrhage (5, 3.3%); seizures (8, 5.3%); cerebral edema (4, 2.6%); pulmonary embolism (4, 2.6%); autonomic failure (2, 1.3%); and hemorrhagic shock (2, 1.3%). Multiple mortal events were identified in 10 (8.5%). Seventy-three patients (48.0%) died at home with hospice. Other locations were inpatient hospice (40, 26.3%); acute care hospital (34, 22.4%), including 27 (17.8%) with and 7 (4.6%) without comfort measures; skilled nursing facility (4, 3.3%), including 3 (2.0%) with and 1 (0.7%) without comfort measures; or religious facility (1, 0.7%) with comfort measures. Acute cardiac or pulmonary resuscitation was performed in 20 patients (13.2%). Discussion Clinical tumor progression was the most common (77.0%) cause of death, followed by infection (12.5%). Hospice or comfort measures were ultimately implemented in 94.7% of patients, although resuscitation was performed in 13.2%. Improved understanding of circumstances surrounding death, frequency of use of hospice services, and frequency of resuscitative efforts in patients with gliomas may allow physicians to more accurately discuss end-of-life expectations with patients and caregivers, facilitating informed care planning.
引用
收藏
页码:E260 / E266
页数:7
相关论文
共 50 条
  • [1] Epilepsy in the end-of-life phase in patients with high-grade gliomas
    Andrea Pace
    Veronica Villani
    Cherubino Di Lorenzo
    Lara Guariglia
    Marta Maschio
    Alfredo Pompili
    Carmine Maria Carapella
    [J]. Journal of Neuro-Oncology, 2013, 111 : 83 - 86
  • [2] Epilepsy in the end-of-life phase in patients with high-grade gliomas
    Pace, Andrea
    Villani, Veronica
    Di Lorenzo, Cherubino
    Guariglia, Lara
    Maschio, Marta
    Pompili, Alfredo
    Carapella, Carmine Maria
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2013, 111 (01) : 83 - 86
  • [3] QUALITY OF END-OF-LIFE CARE IN PATIENTS WITH HIGH GRADE GLIOMAS
    Ou, Alexander
    Harrison, Rebecca
    Liu, Diane
    Naqvi, Mujtaba
    Naqvi, Syed Mussadiq
    O'Brien, Barbara
    Weathers, Shiao-Pei
    de Groot, John
    Bruera, Eduardo
    [J]. NEURO-ONCOLOGY, 2020, 22 : 177 - 177
  • [4] Caregiver perceptions of end-of-life care in patients with high-grade glioma
    Fortunato, John T.
    Van Harn, Meredith
    Haider, Sameah A.
    Phillips, Joel
    Walbert, Tobias
    [J]. NEURO-ONCOLOGY PRACTICE, 2021, 8 (02) : 171 - 178
  • [5] End-of-Life Care in High-Grade Glioma Patients. The Palliative and Supportive Perspective
    Giammalva, Giuseppe Roberto
    Iacopino, Domenico Gerardo
    Azzarello, Giorgio
    Gaggiotti, Claudia
    Graziano, Francesca
    Guli, Carlo
    Pino, Maria Angela
    Maugeri, Rosario
    [J]. BRAIN SCIENCES, 2018, 8 (07):
  • [6] A RETROSPECTIVE STUDY ON CAUSE OF DEATH DUE TO HIGH-GRADE GLIOMAS IN PEDIATRIC VERSUS ADULT PATIENTS
    Franson, Andrea
    Junck, Larry
    Lyons, Samantha
    [J]. NEURO-ONCOLOGY, 2022, 24 : 108 - 108
  • [7] QUALITY OF LIFE IN HIGH-GRADE GLIOMA PATIENTS AND THEIR RELATIVES IN THE END-OF-LIFE PHASE
    Sizoo, E. M.
    Reijneveld, J. C.
    Pasman, H. R. W.
    Heimans, J. J.
    Deliens, L.
    Taphoorn, M. J. B.
    [J]. NEURO-ONCOLOGY, 2010, 12 : 17 - 18
  • [8] End-of-life care in an Australian acute hospital: a retrospective observational study
    Maubach, Ninya
    Batten, Monique
    Jones, Scott
    Chen, Judy
    Scholz, Brett
    Davis, Alison
    Bromley, Jonathan
    Burke, Brandon
    Tan, Ren
    Hurwitz, Mark
    Rodgers, Helen
    Mitchell, Imogen
    [J]. INTERNAL MEDICINE JOURNAL, 2019, 49 (11) : 1400 - 1405
  • [9] The End-of-Life Phase of High-Grade Glioma Patients: Dying With Dignity?
    Sizoo, Eefje M.
    Taphoorn, Martin J. B.
    Uitdehaag, Bernard
    Heimans, Jan J.
    Deliens, Luc
    Reijneveld, Jaap C.
    Pasman, H. Roeline W.
    [J]. ONCOLOGIST, 2013, 18 (02): : 198 - 203
  • [10] A descriptive analysis of end-of-life discussions for high-grade glioma patients
    Chikada, Ai
    Takenouchi, Sayaka
    Arakawa, Yoshiki
    Nin, Kazuko
    [J]. NEURO-ONCOLOGY PRACTICE, 2021, 8 (03) : 345 - 354